Progyny, Inc. (PGNY), a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States.
Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption expenses for clients and their employees.
The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
This stock's revenue and earnings year-to-date have been up over 50% and should continue to grow in the coming weeks to break out of its "bullish cup and handle" formation.
Entry Point: $37.25
Stop Loss: $35.40
Trading Range: $15.59 - $38.75
Target Price: $41.00
PGNY closed at $40.06.